ID: ALA3907170

Max Phase: Preclinical

Molecular Formula: C45H57N3O9S

Molecular Weight: 816.03

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](COCc4ccccc4)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O

Standard InChI:  InChI=1S/C45H57N3O9S/c1-5-7-23-45(6-2)29-58(53,54)37-22-21-34(48(3)4)25-35(37)38(42(45)51)32-19-14-20-33(24-32)46-44(52)47-43-40(50)41(56-27-31-17-12-9-13-18-31)39(49)36(57-43)28-55-26-30-15-10-8-11-16-30/h8-22,24-25,36,38-43,49-51H,5-7,23,26-29H2,1-4H3,(H2,46,47,52)/t36-,38-,39-,40-,41+,42-,43-,45-/m1/s1

Standard InChI Key:  RDBHJJOWBIBYDM-DQBAQLDXSA-N

Associated Targets(Human)

Ileal bile acid transporter 415 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 816.03Molecular Weight (Monoisotopic): 815.3816AlogP: 5.99#Rotatable Bonds: 15
Polar Surface Area: 166.89Molecular Species: NEUTRALHBA: 10HBD: 5
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 3
CX Acidic pKa: 12.49CX Basic pKa: 2.23CX LogP: 6.24CX LogD: 6.24
Aromatic Rings: 4Heavy Atoms: 58QED Weighted: 0.10Np Likeness Score: 0.01

References

1.  (2010)  Novel 1,4-benzothiepine 1,1-dioxide derivatives substituted by benzyl radicals, method for their preparation, pharmaceuticals comprising these compounds, and the use thereof, 

Source